OsteoAMP
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2021 | $95,109 | 201 | 114 |
| 2020 | $52,745 | 90 | 63 |
| 2019 | $166,214 | 309 | 177 |
| 2018 | $105,895 | 214 | 106 |
| 2017 | $191,401 | 208 | 96 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $223,996 | 118 | 36.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $186,475 | 61 | 30.5% |
| Consulting Fee | $125,719 | 50 | 20.6% |
| Food and Beverage | $51,157 | 691 | 8.4% |
| Travel and Lodging | $24,018 | 102 | 3.9% |
Payments by Type
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| A Prospective, Multicenter Study of Instrumented Posterolateral Lumbar Fusions PLF with OsteoAMP to Evaluate Long-Term Safety and Efficacy in Patients Requiring 1-2 Level Instrumented PLF | Bioventus LLC | $182,692 | 0 |
| A Prospective, Randomized Study of Instrumented, Posterolateral Spinal Fusions with OsteoAMP versus Autograft | Bioventus LLC | $22,604 | 2 |
| Use of OSTEOAMP in Lumbar Spine Fusion Surgery A Multi-CenterRetrospective Chart Review Including Independent Image Analysis | Bioventus LLC | $14,550 | 0 |
| Use of OSTEOAMP in Lumbar Spine Fusion Surgery: A Multi-Center Retrospective Chart Review Including Independent Image Analysis | Bioventus LLC | $3,000 | 1 |
| A Prospective, Multicenter Study of Instrumented Posterolateral Lumbar Fusions (PLF) with OsteoAMP to Evaluate Long-Term Safety and Efficacy in Patients Requiring 1-2 Level Instrumented PLF | Bioventus LLC | $1,150 | 0 |
Top Doctors Receiving Payments for OsteoAMP — Page 5
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , DPM | Foot & Ankle Surgery | Warren, MI | $137.13 | 1 |
| , DPM | Foot & Ankle Surgery | Kansas City, MO | $137.13 | 1 |
| , DPM | Foot & Ankle Surgery | Kansas City, MO | $137.13 | 1 |
| Blake Hale | Foot & Ankle Surgery | Kansas City, MO | $137.13 | 1 |
| , DPM | Podiatrist | Kansas City, MO | $137.13 | 1 |
| , DPM | Podiatrist | Saint Joseph, MO | $137.13 | 1 |
| , DPM | Foot & Ankle Surgery | Blue Springs, MO | $137.13 | 1 |
| , MD | Specialist | Houston, TX | $135.65 | 1 |
| , M.D | Orthopaedic Surgery | Hermitage, TN | $134.45 | 2 |
| , MD | Neurological Surgery | Jackson, MI | $133.51 | 2 |
| , DPM | Podiatrist | Loveland, OH | $132.18 | 1 |
| , DPM | Podiatrist | Cincinnati, OH | $132.17 | 1 |
| , DPM | Foot & Ankle Surgery | Cincinnati, OH | $132.17 | 1 |
| , DPM | Podiatrist | Cincinnati, OH | $132.17 | 1 |
| , DPM | Podiatrist | Blue Ash, OH | $132.17 | 1 |
| , D.P.M | Podiatrist | Hamilton, OH | $132.17 | 1 |
| , DPM | Foot & Ankle Surgery | Cincinnati, OH | $132.17 | 1 |
| , DPM, FACFAS | Podiatrist | Cincinnati, OH | $132.17 | 1 |
| , DPM | Podiatrist | Cincinnati, OH | $132.17 | 1 |
| , DPM | Foot & Ankle Surgery | Cincinnati, OH | $132.17 | 1 |
| , DPM | Foot & Ankle Surgery | Blue Ash, OH | $132.17 | 1 |
| , MD | Orthopaedic Surgery of the Spine | Pittston, PA | $130.01 | 1 |
| , M.D | Neurological Surgery | Detroit, MI | $129.69 | 1 |
| , M.D | Neurological Surgery | Detroit, MI | $129.69 | 1 |
| , M.D | Orthopaedic Surgery | Baltimore, MD | $128.74 | 1 |
Manufacturing Companies
- Bioventus LLC $611,364
Product Information
- Type Device
- Total Payments $611,364
- Total Doctors 472
- Transactions 1,022
About OsteoAMP
OsteoAMP is a device associated with $611,364 in payments to 472 healthcare providers, recorded across 1,022 transactions in the CMS Open Payments database. The primary manufacturer is Bioventus LLC.
Payment data is available from 2017 to 2021. In 2021, $95,109 was paid across 201 transactions to 114 doctors.
The most common payment nature for OsteoAMP is "Unspecified" ($223,996, 36.6% of total).
OsteoAMP is associated with 5 research studies, including "A Prospective, Multicenter Study of Instrumented Posterolateral Lumbar Fusions PLF with OsteoAMP to Evaluate Long-Term Safety and Efficacy in Patients Requiring 1-2 Level Instrumented PLF" ($182,692).